Response to Petri: Can a proteomics strategy be used to identify the anti-malarial activity of chloroquine?
Publication
, Journal Article
Haystead, TAJ
Published in: Trends in Pharmacological Sciences
May 1, 2003
Duke Scholars
Published In
Trends in Pharmacological Sciences
DOI
ISSN
0165-6147
Publication Date
May 1, 2003
Volume
24
Issue
5
Start / End Page
212 / 213
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Haystead, T. A. J. (2003). Response to Petri: Can a proteomics strategy be used to identify the anti-malarial activity of chloroquine? Trends in Pharmacological Sciences, 24(5), 212–213. https://doi.org/10.1016/S0165-6147(03)00072-5
Haystead, T. A. J. “Response to Petri: Can a proteomics strategy be used to identify the anti-malarial activity of chloroquine?” Trends in Pharmacological Sciences 24, no. 5 (May 1, 2003): 212–13. https://doi.org/10.1016/S0165-6147(03)00072-5.
Haystead TAJ. Response to Petri: Can a proteomics strategy be used to identify the anti-malarial activity of chloroquine? Trends in Pharmacological Sciences. 2003 May 1;24(5):212–3.
Haystead, T. A. J. “Response to Petri: Can a proteomics strategy be used to identify the anti-malarial activity of chloroquine?” Trends in Pharmacological Sciences, vol. 24, no. 5, May 2003, pp. 212–13. Scopus, doi:10.1016/S0165-6147(03)00072-5.
Haystead TAJ. Response to Petri: Can a proteomics strategy be used to identify the anti-malarial activity of chloroquine? Trends in Pharmacological Sciences. 2003 May 1;24(5):212–213.
Published In
Trends in Pharmacological Sciences
DOI
ISSN
0165-6147
Publication Date
May 1, 2003
Volume
24
Issue
5
Start / End Page
212 / 213
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 11 Medical and Health Sciences
- 06 Biological Sciences